Oral-M
Commercial- Indications
- Oral cancer
Company intelligence / Profile preview
iStat Biomedical has developed a suite of CE-marked in vitro diagnostic kits for early detection of cervical and oral cancers using non-invasive swab samples. Their main products, the PAX1 DNA Detection Kit and ZNF582 DNA Detection Kit, utilize methylation-specific PCR to detect epigenetic biomarkers associated with malignancy. The company also offers auxiliary kits for sample preparation and HPV genotyping. These tests provide clinicians with alternatives to traditional cytology or HPV typing, aiming to reduce unnecessary procedures due to diagnostic uncertainty.[1][3]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iStat Biomedical.